Related Experiment Video
Updated: Jun 20, 2026
13:38
Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
12.4K
A New Pentafluorothio-Substituted Curcuminoid with Superior Antitumor Activity
Benedikt Linder1, Leonhard H F Köhler2, Lisa Reisbeck1
1Experimental Neurosurgery, Frankfurt University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Biomolecules
|July 2, 2021
Summary
A novel curcuminoid compound 1a demonstrates potent anti-cancer effects, outperforming existing treatments. It effectively reduces tumor cell proliferation and triggers apoptosis, showing promise for cancer therapy.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Curcuminoids are known for their anti-tumor properties.
- There is a need for novel anti-cancer agents with improved efficacy.
- Piperidone curcuminoids have shown promise as anti-cancer agents.
Purpose of the Study:
- To synthesize and evaluate a novel pentafluorothiophenyl-substituted N-methyl-piperidone curcuminoid (1a).
- To assess the anti-proliferative, pro-apoptotic, and cancer stem cell-differentiating activities of compound 1a.
- To compare the efficacy of compound 1a with known curcuminoids EF24 (2) and analog 1b.
Main Methods:
- Synthesis of compound 1a.
- In vitro anti-proliferative assays against various human tumor cell lines.
- Cell cycle analysis to assess apoptosis induction.
- Western blotting or activity assays for caspase activation.
- Microscopy to observe morphological changes and cytoskeleton reorganization.
- Assays to evaluate cancer stem cell properties.
Main Results:
- Compound 1a exhibited potent anti-proliferative activity with IC50 values in the nanomolar range.
- 1a demonstrated superior efficacy compared to EF24 (2) and analog 1b across all tested cell lines.
- 1a induced apoptosis in colon adenocarcinoma cells (HT-29) via reactive oxygen species generation and caspase activation.
- Morphological changes, including actin cytoskeleton reorganization, were observed.
- 1a caused cell death in glioblastoma cell lines (U251, Mz54).
- Compound 1a significantly suppressed stem cell properties in glioma stem-like cells.
Conclusions:
- Compound 1a is a highly effective anti-cancer agent with broad-spectrum activity.
- 1a induces cancer cell death through apoptosis and exhibits potent anti-proliferative effects.
- The compound shows significant potential in targeting cancer stem cells, highlighting its therapeutic relevance.
